Literature DB >> 30903609

Cardio-pulmonary involvement in pulmonary arterial hypertension: A perfusion and innervation scintigraphic evaluation.

Alessia Gimelli1, Nicola Riccardo Pugliese2,3, Michelangelo Bertasi1, Edoardo Airò1, Carolina Bauleo1, Bruno Formichi1,4, Renato Prediletto1,4, Paolo Marzullo1,4, Simonetta Monti1,4.   

Abstract

BACKGROUND: Pulmonary arterial hypertension (PAH) is characterized by the right ventricle (RV) remodeling and pulmonary endothelial dysfunction. We studied cardiac perfusion and innervation in PAH with a cadmium-zinc-telluride (CZT) scanner and lung uptake impairment of 123I-metaiodobenzylguanidine (123I-MIBG).
METHODS: In 13 patients with newly diagnosed PAH and 11 dilated cardiomyopathies (DCM, for comparative purposes), we assessed early and delayed 123I-MIBG uptake ratios of lung-to-mediastinum (L/M) and heart-to-mediastinum (H/M) on anterior planar images. A quantitative myocardial innervation with 123I-MIBG and perfusion with 99mTc-tetrofosmin using CZT-SPECT was performed. All patients underwent right heart catheterization.
RESULTS: Early and delayed L/M ratios in PAH were lower than DCM (1.47 ± 0.14 vs 1.98 ± 0.11 and 1.40 ± 0.13 vs 1.83 ± 0.09; P < .001), while early and delayed H/M were impaired but not different (1.73 ± 0.20 vs 1.65 ± 0.18 and 1.73 ± 0.27 vs 1.58 ± 0.19). RV perfusion and early innervation were significantly higher in PAH compared to DCM (68.4 ± 13.4 vs 28.6 ± 4.1 and 58.8 ± 9.3 vs 27 ± 2.2; P < .001); delayed RV innervation was not evaluable. RV/LV perfusion and innervation ratios were significantly related (R = 0.74; P < .0001) and had a significant correlation with clinical, hemodynamic, and morpho-functional parameters, including L/M ratios.
CONCLUSION: Cardio-pulmonary scintigraphy through a perfusion and innervation study is feasible and may identify pulmonary vascular and RV remodeling, as in PAH.

Entities:  

Keywords:  123I-metaiodobenzylguanidine; Pulmonary arterial hypertension; cadmium-zinc-telluride; pulmonary endothelial dysfunction; right ventricle

Mesh:

Substances:

Year:  2019        PMID: 30903609     DOI: 10.1007/s12350-019-01689-w

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  3 in total

1.  Quantitative analysis of regional motion and thickening by gated myocardial perfusion SPECT: normal heterogeneity and criteria for abnormality.

Authors:  T Sharir; D S Berman; P B Waechter; J Areeda; P B Kavanagh; J Gerlach; X Kang; G Germano
Journal:  J Nucl Med       Date:  2001-11       Impact factor: 10.057

2.  Correlation between severity of pulmonary arterial hypertension and 123I-metaiodobenzylguanidine left ventricular imaging.

Authors:  F Sakamaki; T Satoh; N Nagaya; S Kyotani; H Oya; N Nakanishi; S Kuribayashi; Y Ishida
Journal:  J Nucl Med       Date:  2000-07       Impact factor: 10.057

3.  In vivo evidence of endothelial injury in chronic obstructive pulmonary disease by lung scintigraphic assessment of (123)I-metaiodobenzylguanidine.

Authors:  Tsuyoshi Arao; Noriaki Takabatake; Makoto Sata; Shuichi Abe; Yoko Shibata; Tsuguo Honma; Kazuei Takahashi; Akio Okada; Yasuchika Takeishi; Isao Kubota
Journal:  J Nucl Med       Date:  2003-11       Impact factor: 10.057

  3 in total
  1 in total

1.  The potential for early diagnosis of pulmonary arterial hypertension using lung iodine-123-metaiodobenzylguanidine (123I-MIBG) uptake: A case report.

Authors:  Kenjuro Higo; Kayoko Kubota; Sawako Hiwatari Takeshita; Noriko Iwatani; Sunao Minayaga; Megumi Jinguji; Mitsuru Ohishi
Journal:  Radiol Case Rep       Date:  2020-06-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.